Enanta Pharmaceuticals (ENTA)

Add to Watchlists
Create an Alert
38.87 -0.25  -0.64% NASDAQ Sep 4, 20:00 Delayed 2m USD
View Full Chart
ENTA Price Chart
View All Performance Charts

ENTA Total Returns Comparison

PDF Report for ENTA

Download ENTA Pro Report PDF
Advertisement

ENTA Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.enanta.com
  • IR Website: http://ir.enanta.com/phoenix.zhtml?c=147990&p=irol-irhome
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: September 30, 2015
  • Last Fiscal Quarter End: June 30, 2015
  • Last Fiscal Year End: September 30, 2014
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Enanta Pharmaceuticals Inc is a biotechnology company. It is engaged in the research and development of small molecule drugs for infectious diseases. The Company uses its chemistry-driven approach & drug discovery capabilities to develop its products.

ENTA Excel Add-In Codes

  • Name: =YCI("ENTA","name")
  • Description: =YCI("ENTA","description")
  • Sector: =YCI("ENTA","sector")
  • Industry: =YCI("ENTA","industry")
  • Est. Current Fiscal Year End: =YCI("ENTA","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.